BENKOWITZ MICHAEL
SEC CIK 1673232 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | Pres, COO | 33.8K | — | $350.42M | 172 | 2021-08-05 | 2026-03-15 |
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $844.54M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
Transactions 172
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-03-17 | 2026-03-15 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | — | +33.4K | 33.8K | +9,022% | — |
| DMI | 2026-03-17 | 2026-03-15 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | F - Tax | $536.12 | -14.7K | 25.9K | -36% | -$7.88M |
| DMTI | 2026-02-24 | 2026-02-23 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $127.68 | +14.4K | 5,065 | New | +$1.84M |
| DMTI | 2026-02-24 | 2026-02-23 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $472.13 | -14.4K | 0 | -100% | -$6.82M |
| DMTI | 2026-02-18 | 2026-02-17 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $127.65 | +22.5K | 14.6K | New | +$2.87M |
| DMTI | 2026-02-18 | 2026-02-17 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $480.75 | -22.5K | 0 | -100% | -$10.82M |
| DMTI | 2026-02-10 | 2026-02-09 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $474.65 | -22.5K | 0 | -100% | -$10.68M |
| DMTI | 2026-02-10 | 2026-02-09 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $127.65 | +22.5K | 14.6K | New | +$2.87M |
| DMTI | 2026-02-03 | 2026-02-02 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $127.65 | +22.5K | 7,875 | New | +$2.87M |
| DMTI | 2026-02-03 | 2026-02-02 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $470.95 | -22.5K | 0 | -100% | -$10.60M |
| DMTI | 2026-01-28 | 2026-01-20+ | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $132.42 | +30.4K | 7,875 | New | +$4.02M |
| DMTI | 2026-01-28 | 2026-01-20+ | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $470.03 | -30.4K | 549 | -98% | -$14.28M |
| DMTI | 2026-01-28 | 2026-01-20 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $464.66 | -14.6K | 13.1K | -53% | -$6.80M |
| DTI | 2026-01-28 | 2026-01-20 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $117.76 | -14.6K | 14.6K | -50% | -$1.72M |
| DMTI | 2026-01-13 | 2026-01-12 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $479.51 | -22.5K | 0 | -100% | -$10.79M |
| DMTI | 2026-01-13 | 2026-01-12 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $127.65 | +22.5K | 14.6K | New | +$2.87M |
| DMTI | 2026-01-07 | 2026-01-05 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $487.37 | -7,875 | 4,234 | -65% | -$3.84M |
| DTI | 2026-01-07 | 2026-01-05 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $146.03 | +7,875 | 7,875 | New | +$1.15M |
| DMTI | 2026-01-07 | 2026-01-05 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $487.38 | -14.6K | 9,532 | -61% | -$7.13M |
| DTI | 2026-01-07 | 2026-01-05 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $117.76 | +14.6K | 14.6K | New | +$1.72M |
| DMTI | 2025-12-30 | 2025-12-29 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $127.65 | -6,750 | 7,875 | -46% | -$861.7K |
| DMTI | 2025-12-30 | 2025-12-29 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $502.79 | -22.5K | 0 | -100% | -$11.31M |
| DMTI | 2025-12-29 | 2025-12-22 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $514.36 | -22.5K | 0 | -100% | -$11.57M |
| DMTI | 2025-12-29 | 2025-12-22 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $127.65 | -6,750 | 7,875 | -46% | -$861.7K |
| DMTI | 2025-12-16 | 2025-12-15 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $496.30 | -22.5K | 14.4K | -61% | -$11.17M |
| DMTI | 2025-12-16 | 2025-12-15 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $244.05 | +22.5K | 14.6K | New | +$5.49M |
| DMTI | 2025-12-09 | 2025-12-08 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $478.58 | -22.5K | 0 | -100% | -$10.77M |
| DMTI | 2025-12-09 | 2025-12-08 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $244.05 | +22.5K | 7,875 | New | +$5.49M |
| DMTI | 2025-12-02 | 2025-12-01 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $479.92 | -22.5K | 2,263 | -91% | -$10.80M |
| DMTI | 2025-12-02 | 2025-12-01 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $127.65 | +22.5K | 7,875 | New | +$2.87M |
| DMTI | 2025-11-26 | 2025-11-24 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $473.66 | -22.5K | 0 | -100% | -$10.66M |
| DMTI | 2025-11-26 | 2025-11-24 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $137.07 | +22.5K | 12.0K | New | +$3.08M |
| DMTI | 2025-11-18 | 2025-11-17 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $139.13 | +22.5K | 7,875 | New | +$3.13M |
| DMTI | 2025-11-18 | 2025-11-17 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $470.43 | -22.5K | 0 | -100% | -$10.58M |
| DMTI | 2025-11-12 | 2025-11-10 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $139.13 | -6,750 | 7,875 | -46% | -$939.2K |
| DMTI | 2025-11-12 | 2025-11-10 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $452.07 | -22.5K | 0 | -100% | -$10.17M |
| DMTI | 2025-11-04 | 2025-11-03 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $429.25 | -22.5K | 11.0K | -67% | -$9.66M |
| DMTI | 2025-11-04 | 2025-11-03 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $139.13 | +22.5K | 14.6K | New | +$3.13M |
| DMTI | 2025-10-28 | 2025-10-27 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $139.13 | +22.5K | 6,125 | New | +$3.13M |
| DMTI | 2025-10-28 | 2025-10-27 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $417.50 | -22.5K | 130 | -99% | -$9.39M |
| DMTI | 2025-10-21 | 2025-10-20 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $139.13 | +22.5K | 7,875 | New | +$3.13M |
| DMTI | 2025-10-21 | 2025-10-20 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $427.41 | -22.5K | 0 | -100% | -$9.62M |
| DMTI | 2025-10-15 | 2025-10-13 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $440.35 | -22.5K | 0 | -100% | -$9.91M |
| DMTI | 2025-10-15 | 2025-10-13 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $139.13 | +22.5K | 14.6K | New | +$3.13M |
| DMTI | 2025-10-07 | 2025-10-06 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $450.24 | -22.5K | 14.2K | -61% | -$10.13M |
| DMTI | 2025-10-07 | 2025-10-06 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $139.13 | +22.5K | 14.6K | New | +$3.13M |
| DMTI | 2025-10-01 | 2025-09-29 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $421.80 | -22.5K | 96 | -100% | -$9.49M |
| DMTI | 2025-10-01 | 2025-09-29 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $139.13 | +22.5K | 7,875 | New | +$3.13M |
| DMTI | 2025-09-24 | 2025-09-22 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $139.13 | +22.5K | 7,875 | New | +$3.13M |
| DMTI | 2025-09-24 | 2025-09-22 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $416.35 | -22.5K | 0 | -100% | -$9.37M |
| DMI | 2025-09-17 | 2025-09-15 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $139.13 | +22.5K | 7,875 | New | +$3.13M |
| DMI | 2025-09-17 | 2025-09-15 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $400.56 | -22.5K | 14.3K | -61% | -$9.01M |
| DMTI | 2025-09-10 | 2025-09-08+ | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $395.83 | -16.4K | 6,500 | -72% | -$6.48M |
| DMTI | 2025-09-10 | 2025-09-08+ | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $318.55 | +16.4K | 11.4K | New | +$5.22M |
| DMTI | 2025-09-04 | 2025-09-02 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $417.64 | -22.5K | 6,220 | -78% | -$9.40M |
| DMTI | 2025-09-04 | 2025-09-01+ | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $139.13 | +22.5K | 14.6K | New | +$3.13M |
| DMTI | 2025-03-11 | 2025-03-10 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $320.09 | -2,000 | 1,807 | -53% | -$640.2K |
| DTI | 2025-03-11 | 2025-03-10 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $111.00 | +2,000 | 2,000 | New | +$222.0K |
| DMTI | 2025-03-04 | 2025-03-03 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $111.00 | +9,679 | 7,179 | New | +$1.07M |
| DMTI | 2025-03-04 | 2025-03-03 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $311.99 | -9,679 | 1,000 | -91% | -$3.02M |
| DMTI | 2025-02-25 | 2025-02-24 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $360.76 | -10.0K | 6,021 | -62% | -$3.61M |
| DMTI | 2025-02-25 | 2025-02-24 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $111.00 | +10.0K | 7,500 | New | +$1.11M |
| DMTI | 2025-02-19 | 2025-02-18 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $111.00 | +10.0K | 2,500 | New | +$1.11M |
| DMTI | 2025-02-19 | 2025-02-18 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $371.05 | -10.0K | 599 | -94% | -$3.71M |
| DMTI | 2025-02-11 | 2025-02-10 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $348.06 | -10.0K | 6,358 | -61% | -$3.48M |
| DMTI | 2025-02-11 | 2025-02-10 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $111.00 | +10.0K | 7,500 | New | +$1.11M |
| DMTI | 2025-02-04 | 2025-02-03 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $111.00 | +10.0K | 7,500 | New | +$1.11M |
| DMTI | 2025-02-04 | 2025-02-03 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $353.64 | -10.0K | 4,009 | -71% | -$3.54M |
| DMTI | 2025-01-28 | 2025-01-27 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $111.00 | +10.0K | 2,500 | New | +$1.11M |
| DMTI | 2025-01-28 | 2025-01-27 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $370.71 | -10.0K | 0 | -100% | -$3.71M |
| DMTI | 2025-01-22 | 2025-01-21 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $364.91 | -10.0K | 1,600 | -86% | -$3.65M |
| DMTI | 2025-01-22 | 2025-01-21 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $111.00 | +10.0K | 2,500 | New | +$1.11M |
| DMTI | 2025-01-14 | 2025-01-13 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $364.62 | -10.0K | 600 | -94% | -$3.65M |
| DMTI | 2025-01-14 | 2025-01-13 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $111.00 | +10.0K | 7,500 | New | +$1.11M |
| DMTI | 2025-01-07 | 2025-01-06 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $355.15 | -10.0K | 300 | -97% | -$3.55M |
| DMTI | 2025-01-07 | 2025-01-06 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $111.00 | +10.0K | 7,500 | New | +$1.11M |
| DMTI | 2024-12-31 | 2024-12-30 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $356.68 | -10.0K | 6,182 | -62% | -$3.57M |
| DMTI | 2024-12-31 | 2024-12-30 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $111.00 | +10.0K | 7,500 | New | +$1.11M |
| DMTI | 2024-12-26 | 2024-12-23 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $111.00 | +10.0K | 2,500 | New | +$1.11M |
| DMTI | 2024-12-26 | 2024-12-23 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $361.95 | -10.0K | 800 | -93% | -$3.62M |
| DMTI | 2024-12-17 | 2024-12-16 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $370.14 | -10.0K | 1,705 | -85% | -$3.70M |
| DMTI | 2024-12-17 | 2024-12-16 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $111.00 | +10.0K | 3,352 | New | +$1.11M |
| DMTI | 2024-12-10 | 2024-12-09 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $367.68 | -10.0K | 178 | -98% | -$3.68M |
| DMTI | 2024-12-10 | 2024-12-09 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $107.00 | +10.0K | 4,500 | New | +$1.07M |
| DMI | 2024-12-03 | 2024-12-02 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $104.33 | +10.0K | 2,500 | New | +$1.04M |
| DMI | 2024-12-03 | 2024-12-02 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $370.51 | -10.0K | 5,521 | -64% | -$3.71M |
| DMI | 2024-11-27 | 2024-11-25 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $372.76 | -10.0K | 2,216 | -82% | -$3.73M |
| DMI | 2024-11-27 | 2024-11-25 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $104.33 | +10.0K | 2,500 | New | +$1.04M |
| DMI | 2024-11-19 | 2024-11-18 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $359.21 | -10.0K | 1,136 | -90% | -$3.59M |
| DMI | 2024-11-19 | 2024-11-18 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $104.33 | +10.0K | 7,500 | New | +$1.04M |
| DMI | 2024-11-12 | 2024-11-11 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $407.32 | -15.0K | 7,550 | -67% | -$6.11M |
| DMI | 2024-11-12 | 2024-11-11 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $104.33 | +15.0K | 11.2K | New | +$1.56M |
| DMI | 2024-11-08 | 2024-11-06+ | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $398.85 | -25.0K | 6,700 | -79% | -$9.97M |
| DMI | 2024-11-08 | 2024-11-06+ | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $107.60 | +25.0K | 7,500 | New | +$2.69M |
| DMI | 2024-11-04 | 2024-11-01 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $374.46 | -14.7K | 14.5K | -50% | -$5.50M |
| DI | 2024-11-04 | 2024-11-01 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $120.26 | +14.7K | 14.7K | New | +$1.77M |
| DMI | 2024-08-08 | 2024-08-07 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $118.41 | +25.0K | 5,000 | New | +$2.96M |
| DMI | 2024-08-08 | 2024-08-07 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $323.38 | -25.0K | 16.9K | -60% | -$8.08M |
| D | 2024-05-07 | 2024-05-06 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $163.30 | +32.2K | 34.8K | +1,250% | +$5.26M |
| D | 2024-05-07 | 2024-05-06 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | D - Sale to Iss | $260.51 | -32.2K | 2,577 | -93% | -$8.39M |
Purchase Sale Sale after option exercise All abbreviations